K-M analysis indicated that OS of HER2-low-positive BC seemed to be better than HER2-0 BC (92% vs. 90%, p=0.097, Figure 1), while no significant difference of RFS (p=0.33) and BCSS (p=0.2) could be found between the two groups. Here, ERBB2 is linked to breast cancer.